GlaxoSmithKline
Last updated on 2013-11-22T06:52+0300.
About this
image
License:
UNKNOWN
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|---|---|---|
| british rival | 50.00% | EN | 02/02/2007 |
| candidate | 50.00% | EN | 15/11/2005 |
| Names | Lang | Count |
|---|---|---|
| GlaxoSmithKline | EN | 22.94% |
| GlaxoSmithKline | FR | 8.56% |
| GlaxoSmithKline | PT | 5.87% |
| GlaxoSmithKline | ES | 5.26% |
| GlaxoSmithKline | DE | 5.20% |
| GlaxoSmithKline | AF | 5.20% |
| GlaxoSmithKline | PL | 5.20% |
| GlaxoSmithKline | TR | 5.20% |
| GlaxoSmithKline | NN | 5.20% |
| GlaxoSmithKline | RU | 5.20% |
| GlaxoSmithKline | NO | 5.20% |
| GlaxoSmithKline | UK | 5.20% |
| GlaxoSmithKline | HR | 5.20% |
| GlaxoSmithKline | AR | 5.20% |
| Glaxo Smith Kline | EN | 0.98% |
| GLAXOSMITHKLINE | EN | 0.90% |
| Glaxo Smith Kline | FR | 0.90% |
| Glaxo Smith Kline | SV | 0.84% |
| Glaxo-Smith-Kline | DE | 0.53% |
| GlaxoSmithKline | SA | 0.39% |
| Glaxo Smithkline | ES | 0.29% |
| Glaxo Smithkline | EN | 0.29% |
| Glaxo Smith Klein | EN | 0.12% |
| Glaxo SmithKline | EN | 0.10% |
| GLAXOSMITHKLINE | FR | 0.06% |
| Glaxo Smithkline | FR | 0.02% |
| GLAXOSMITHKLINE | SA | 0.02% |
| Pharmakonzern Glaxo Smithkline | DE | 0.00% |
| 葛蘭素史克 | ZH | 0.00% |
| Pharmariesen Glaxo Smith Kline | DE | 0.00% |
| Type | Entity Name | Count |
|---|---|---|
 | Inc | 4.24% |
| Pfizer Inc | 3.81% |
| Eli Lilly | 3.07% |
| Reuters Group | 2.86% |
| GlaxoSmithKline Plc | 2.75% |
| European Union | 2.65% |
| Drug Administration | 2.65% |
| World Health Organization | 2.65% |
| Novartis | 2.01% |
 | British | 2.01% |
| United Nations | 1.69% |
| Pharmaceuticals Inc | 1.06% |
| Morgan Stanley | 1.06% |
| Laura Wood | 0.95% |
| Commission | 0.95% |
| 0.95% | |
| Luke Miels | 0.95% |
| European Medicines Agency | 0.85% |
| Emma Walmsley | 0.85% |
| UNCTAD | 0.85% |
| UN Conference | 0.85% |
| Dietmar Hopp | 0.74% |
| SA | 0.74% |
| Medicines Agency | 0.74% |
| Dow Jones | 0.74% |
| Washington University School | 0.74% |
| Swedish | 0.64% |
| German government | 0.64% |
| AstraZeneca PLC | 0.64% |
| Johns Hopkins | 0.64% |
| Type | Entity Name | Score |
|---|---|---|
| Vikas Bhagat | 0.0588 |
| Jo Brewis | 0.0526 |
| Massimiliano Di Domenico | 0.0345 |
| Erol Fikrig | 0.0333 |
| Eli Lilly | 0.0262 |
| GlaxoSmithKline Plc | 0.0261 |
| Novartis | 0.018 |
| Drug Administration | 0.0153 |
| Luke Miels | 0.0122 |
| Pharmaceuticals Inc | 0.0094 |
| Tamara Rogers | 0.0084 |
| Morgan Stanley | 0.008 |
| Emma Walmsley | 0.0079 |
| UNCTAD | 0.0077 |
| Laura Wood | 0.0074 |
| Pfizer Inc | 0.0072 |
| UN Conference | 0.0072 |
| Tekmira Pharmaceuticals | 0.0071 |
| Dietmar Hopp | 0.007 |
| European Medicines Agency | 0.0068 |
| Washington University School | 0.0064 |
| AstraZeneca PLC | 0.0061 |
| Medicines Agency | 0.0059 |
| Elliott Management | 0.0058 |
| Michael Hewson | 0.0058 |
| Daniel Kretinsky | 0.0057 |
| Compass Group | 0.0057 |
| Evraz Group | 0.0055 |
| Inc | 0.0054 |
| German government | 0.0054 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Thursday, August 11, 2022
2:47:00 AM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 